£1.72m
+1%vs Apr 2024Active10509764Private limited companySedgefield
NORTHUMBRIA PHARMA LTD
Significant control: Northumbria Pharma Group Holdings Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Northumbria Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Northumbria Pharma Ltd sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NORTHUMBRIA PHARMA LTD is an active private limited company (company number 10509764) incorporated on 5 December 2016, registered in Sedgefield. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest full accounts cover the period ending 30 April 2025, showing net assets of £1.72m and cash of £5.33m, with 29 employees on average. Net assets rose 1% on the prior period (£1.71m).
Peer position · net assets
By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Northumbria Pharma Group Holdings Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Paul Watson
- owns 50–75% of shares
- holds 50–75% of voting rights
- Dr Samer Taslaq
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 5 December 20169 yrs ago
- Next accounts due
- 30 January 2027in 98 days
- Confirmation statement due
- 19 December 2026in 56 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£5.33m
+340%vs Apr 2024Not reported
29
+4%vs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £1.72m | £5.33m | £21.62m | £37.06m | — | £11k | 29 |
| 30 April 2024 | £1.71m | £1.21m | £1.53m | £3.48m | — | £115k | 28 |
| 30 April 2023 | — | — | — | — | — | — | — |
Current ratio1.03Current assets ÷ creditors within one year
Cash per employee£184kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,720,343 at 30 April 2025
- Cash at bank of £50,000 or moreCash £5,330,325
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 5 December 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 98 days
- Confirmation statement duein 56 days
- Accounts period endNet assets £1.72m · full accounts
- Accounts period endNet assets £1.71m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Teesside
09
Reminders for NORTHUMBRIA PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.